First Trust NYSE Arca Biotechnology Index Fund

ETFs attract strong inflows in March, but not ‘all boats’ were lifted. Here’s where the money flowed—and where it didn’t.

2:32 p.m. April 9, 2022

- Christine Idzelis

ETF Wrap: Fiscal stimulus Groundhog Day, and betting on volatility

8:29 a.m. Oct. 23, 2020

- Andrea Riquier

The best sector of this bull market is the ‘greatest investment story ever told’

5:29 p.m. March 8, 2018

- Ryan Vlastelica

Small Is Best for Biotech ETFs

12:17 a.m. Dec. 23, 2017

- Barron's Online

ETF Topper: Biotechnology Isn’t Totally on the Outs

5:29 p.m. Aug. 22, 2017

- Barrons Blogs

ETF Topper: Biotech Stocks Break Out

5:07 p.m. July 20, 2017

- Barrons Blogs

ETF Flopper: Biotech Stumbles on Health Care Vote Delay

4:43 p.m. June 27, 2017

- Barrons Blogs

Forbidden Technologies shares dive as CEO quits

10:46 a.m. Feb. 22, 2017

- MarketWatch.com

This ETF has jumped sevenfold since the start of the bull market

11:20 a.m. Nov. 30, 2016

- Ryan Vlastelica

Illumina’s Pain Infects Biotech ETFs

11:07 a.m. Oct. 11, 2016

- Barrons Blogs

Greenwich LifeSciences: A First Look

11:12 a.m. Today11:12 a.m. May 19, 2022

- Seeking Alpha

Novavax: Buying Here Will Not End Well

2:16 p.m. May 18, 2022

- Seeking Alpha

Organogenesis Holdings: What Now

1:46 p.m. May 18, 2022

- Seeking Alpha

Exelixis: Becoming A Giant Pharma

11:20 a.m. May 18, 2022

- Seeking Alpha

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

6:20 a.m. May 18, 2022

- Zacks.com

Investing For Growth In A Decelerating World Economy

9:52 a.m. May 12, 2022

- Seeking Alpha

Cryoport: To Resume Aggressive Growth

3:18 p.m. May 11, 2022

- Seeking Alpha

Cue Biopharma: A First Assessment

10:25 a.m. May 11, 2022

- Seeking Alpha

Agios: Approved Product, Upcoming Catalysts

1:22 p.m. May 10, 2022

- Seeking Alpha

BioMarin: A Good Anchor For Your Biotech Portfolio

1:13 p.m. May 10, 2022

- Seeking Alpha